| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.5M | +304.8% |
| Cost of Revenue | $14.5M | +363.0% |
| Gross Profit | $2.0M | +112.5% |
| R&D Expense | $679K | -10.1% |
| SG&A Expense | $1.6M | -6.5% |
| Interest Expense | $1.5M | — |
| Income Tax | $0 | — |
| Net Income | -$33.4M | -2523.8% |
| EPS (Basic) | -$1.00 | -1150.0% |
| EPS (Diluted) | -$1.00 | -1150.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -22.8% |
| Current Assets | $214.0M | +461.2% |
| Total Assets | $214.6M | +461.2% |
| Current Liabilities | $63.4M | +1392.7% |
| Total Liabilities | $75.2M | +1671.7% |
| Stockholders' Equity | $139.4M | +310.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | -177.2% |
| Capital Expenditures | $13K | +381.8% |
| Investing Cash Flow | -$197.5M | -7403.1% |
| Financing Cash Flow | $206.8M | +2995.4% |
| Free Cash Flow | -$9.8M | -177.3% |